Barclays’s LifePoint Health, Inc. LPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-118,891
| Closed | -$7.66M | – | 7819 |
|
|
2018
Q3 | $7.66M | Buy |
118,891
+76,045
| +177% | +$4.63M | 0.01% | 1452 |
|
|
2018
Q2 | $2.09M | Buy |
42,846
+8,443
| +25% | +$437K | ﹤0.01% | 2550 |
|
|
2018
Q1 | $1.62M | Buy |
34,403
+11,817
| +52% | +$569K | ﹤0.01% | 2697 |
|
|
2017
Q4 | $1.13M | Sell |
22,586
-41,640
| -65% | -$2.07M | ﹤0.01% | 3005 |
|
|
2017
Q3 | $3.72M | Sell |
64,226
-17,941
| -22% | -$1.07M | ﹤0.01% | 1768 |
|
|
2017
Q2 | $5.52M | Buy |
82,167
+1,869
| +2% | +$118K | 0.01% | 1390 |
|
|
2017
Q1 | $5.26M | Sell |
80,298
-10,288
| -11% | -$636K | 0.01% | 1288 |
|
|
2016
Q4 | $5.14M | Buy |
90,586
+84,453
| +1,377% | +$4.89M | 0.01% | 1365 |
|
|
2016
Q3 | $364K | Sell |
6,133
-104,309
| -94% | -$6.26M | ﹤0.01% | 3498 |
|
|
2016
Q2 | $7.22M | Buy |
110,442
+85,192
| +337% | +$5.79M | 0.01% | 1049 |
|
|
2016
Q1 | $1.74M | Buy |
25,250
+20,246
| +405% | +$1.35M | ﹤0.01% | 2050 |
|
|
2015
Q4 | $365K | Sell |
5,004
-491
| -9% | -$34.9K | ﹤0.01% | 3448 |
|
|
2015
Q3 | $385K | Sell |
5,495
-7,180
| -57% | -$583K | ﹤0.01% | 3583 |
|
|
2015
Q2 | $1.09M | Sell |
12,675
-11,799
| -48% | -$892K | ﹤0.01% | 2808 |
|
|
2015
Q1 | $1.79M | Buy |
24,474
+6,283
| +35% | +$446K | ﹤0.01% | 2428 |
|
|
2014
Q4 | $1.29M | Sell |
18,191
-4,896
| -21% | -$339K | ﹤0.01% | 2948 |
|
|
2014
Q3 | $1.59M | Sell |
23,087
-13,406
| -37% | -$942K | ﹤0.01% | 2884 |
|
|
2014
Q2 | $2.26M | Sell |
36,493
-18,080
| -33% | -$1.06M | ﹤0.01% | 2466 |
|
|
2014
Q1 | $2.95M | Buy |
54,573
+8,034
| +17% | +$429K | ﹤0.01% | 2184 |
|
|
2013
Q4 | $2.42M | Sell |
46,539
-33,103
| -42% | -$1.66M | ﹤0.01% | 2474 |
|
|
2013
Q3 | $3.66M | Buy |
79,642
+24,912
| +46% | +$1.19M | ﹤0.01% | 1972 |
|
|
2013
Q2 | $2.67M | Buy |
+54,730
| New | +$2.62M | ﹤0.01% | 2222 |
|
Other funds holding LPNT
Barclays's LPNT Position: Q4 2018 in Review
Barclays sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 118,891 shares — an estimated $7.66M sold.
Barclays first reported a position in LPNT in Q2 2013 and held it in 22 quarters. The position peaked at $7.66M in Q3 2018. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.
- Barclays reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
- Barclays sold 118,891 LifePoint Health, Inc. shares in Q4 2018, an estimated $7.66M.
- Barclays first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 22 quarters.
- Barclays's LifePoint Health, Inc. position peaked at $7.66M in Q3 2018.
- 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.